Phibro Animal Health Corporation provided consolidated earnings guidance for the year ending June 30, 2024. For the year, the company expects Net sales of $980 million to $1.02 billion, growth of 2%, Net income of $23 million to $28 million, a decline of 22% and Diluted EPS of $0.57 to $0.69, a decline of 22%.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.55 USD | -0.85% | +2.81% | +51.55% |
05-09 | Transcript : Phibro Animal Health Corporation, Q3 2024 Earnings Call, May 09, 2024 | |
05-08 | Earnings Flash (PAHC) PHIBRO ANIMAL HEALTH CORPORATION Posts Q3 EPS $0.31, vs. Street Est of $0.29 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+51.55% | 711M | |
-14.35% | 77.13B | |
+14.09% | 8.4B | |
-0.70% | 3.22B | |
+14.70% | 1.64B | |
-10.12% | 1.5B | |
-22.60% | 1.3B | |
-4.20% | 1.25B | |
-10.26% | 1.18B | |
+5.06% | 1.1B |
- Stock Market
- Equities
- PAHC Stock
- News Phibro Animal Health Corporation
- Phibro Animal Health Corporation Provides Consolidated Earnings Guidance for the Year Ending June 30, 2024